XNAS
MEDS
Market cap8mUSD
Oct 22, Last price
2.30USD
1D
-15.44%
1Q
-27.44%
IPO
-98.76%
Name
Wellgistics Health Inc
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
244.72%
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
23m
+28.73%
Net income
-101m
L+1,377.12%
CFO
-11m
L+786.13%
Dividend
Jul 19, 20241.5 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.
Key people
Prashant Patel
President, Interim Chief Executive Officer, Director · since 2025
Brian Norton
Chief Executive Officer · since 2025
Mark Disiena
Chief Financial Officer · since 2025
Nikul Panchal
President, Healthcare Operations
Charles Wilson
Chief Operating Officer
Brett Bryant
Executive Vice President Supply Chain Operations
Shafaat Pirani
Executive Vice President Healthcare Operations
Brett Thompson
Chief Technology Officer, Vice President - Technology
Scott Madsen
Vice President - Finance
Doug Edmund
Director of Compliance
Chairman of the Board · since 2023
Donald Fell
Independent Director · since 2025
Michael Peterson
Independent Director · since 2025
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | |
| Income | ||||
Revenues | ||||
Cost of revenue | ||||
Unusual Expense (Income) | ||||
NOPBT | ||||
NOPBT Margin | ||||
Operating Taxes | ||||
Tax Rate | ||||
NOPAT | ||||
Net income | ||||
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | ||||
BB yield | ||||
| Debt | ||||
Debt current | ||||
Long-term debt | ||||
Deferred revenue | ||||
Other long-term liabilities | ||||
Net debt | ||||
| Cash flow | ||||
Cash from operating activities | ||||
CAPEX | ||||
Cash from investing activities | ||||
Cash from financing activities | ||||
FCF | ||||
| Balance | ||||
Cash | ||||
Long term investments | ||||
Excess cash | ||||
Stockholders' equity | ||||
Invested Capital | ||||
ROIC | ||||
ROCE | ||||
| EV | ||||
Common stock shares outstanding | ||||
Price | ||||
Market cap | ||||
EV | ||||
EBITDA | ||||
EV/EBITDA | ||||
Interest | ||||
Interest/NOPBT |